Journal of the Neurological Sciences
Volume 215, Issue 1 , Pages 45-50 , 15 November 2003

Magnetic resonance imaging demonstrates differential atrophy of pontine base and tegmentum in Machado–Joseph disease

Received 12 February 2003 ,Revised 3 June 2003 ,Accepted 6 June 2003.

References 

  1. Kawaguchi Y, Okamoto T, Taniwaki M, Aizawa M, Inoue M, Katayama S, et al.  CAG expansions in a novel gene for Machado–Joseph disease at chromosome 14q32.1. Nat. Genet. 1994;8:221–228
  2. Ikeda H, Yamaguchi M, Sugai S, Aze Y, Narumiya S, Kakizuka A. Expanded polyglutamine in the Machado–Joseph disease protein induces cell death in vitro and in vivo. Nat. Genet. 1996;13:196–202
  3. Paulson HL, Perez MK, Trottier Y, Trajanowski JQ, Subramony SH, Das SS, et al.  Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3. Neuron. 1997;19:333–344
  4. Yoshizawa T, Yamagishi Y, Koseki N, Goto J, Yoshida H, Shibasaki F, et al.  Cell cycle arrest enhances the in vitro cellular toxicity of the truncated Machado–Joseph disease gene product with an expanded polyglutamine stretch. Hum. Mol. Genet. 2000;9:69–78
  5. Yuasa T, Ohama E, Harayama H, Yamada M, Kawase Y, Wakabayashi M, et al.  Joseph's disease: clinical and pathologic studies in a Japanese family. Ann. Neurol. 1986;19:152–157
  6. Dürr A, Stevanin G, Cancel G, Duyckaerts C, Abbas N, Didierjean O, et al.  Spinocerebellar ataxia 3 and Machado–Joseph disease: clinical, molecular, and neuropathological features. Ann. Neurol. 1996;39:490–499
  7. Iwabuchi K, Tsuchiya K, Uchihara T, Yagishitra S. Autosomal dominant spinocerebellar degenerations. Clinical, pathological, and genetic correlations. Rev. Neurol. (Paris). 1999;155:255–270
  8. Murata Y, Yamaguchi S, Kawakami H, Imon Y, Maruyama H, Sakai T, et al.  Characteristic magnetic resonance imaging findings in Machado–Joseph disease. Arch. Neurol. 1998;55:33–37
  9. Onodera O, Idezuka J, Igarashi S, Takiyama Y, Endo K, Takano H, et al.  Progressive atrophy of cerebellum and brainstem as a function of age and size of the expanded CAG repeats in the MJD1 gene in Machado–Joseph disease. Ann. Neurol. 1998;43:288–296
  10. Abe Y, Tanaka F, Matsumoto M, Doyu M, Hirayama M, Kachi T, et al.  CAG repeat number correlates with the rate of brainstem and cerebellar atrophy in Machado–Joseph disease. Neurology. 1998;51:882–884
  11. Hirayama K, Takayanagi T, Yanagisawa N. Ataxic diseases (spinocerebellar degenerations and Shy-Drager syndrome): epidemiologic study. Annual report of research committee for ataxic diseases; 1990.
  12. Furtado S, Suchowersky O, Rewcastle B, Graham L, Klimek ML, Garber A. Relationship between trinucleotide repeats and neuropathological changes in Huntington's disease. Ann. Neurol. 1996;39:132–136
  13. Penney JB, Vonsattel JP, MacDonald ME, Gusella JF, Myers RH. CAG repeat number governs the development rate of pathology in Huntington's disease. 1997;41:689–92.
  14. Yoshizawa T, Yoshida H, Shoji S. Differential susceptibility of cultured cell lines to aggregate formation and cell death produced by the truncated Machado–Joseph disease gene product with an expanded polyglutamine stretch. Brain Res. Bull. 2001;56:349–352

PII: S0022-510X(03)00185-0

doi: 10.1016/S0022-510X(03)00185-0

Journal of the Neurological Sciences
Volume 215, Issue 1 , Pages 45-50 , 15 November 2003

Article Tools

* Image Usage & Resolution